Optimizing Treatment of Parkinson's Disease.
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
09 Feb 2022
09 Feb 2022
Historique:
received:
04
02
2022
accepted:
05
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
The holy grail of therapy in Parkinson's disease (PD) is treatment that would halt the disease process or restore the degenerated neuronal circuits [...].
Identifiants
pubmed: 35207734
pii: jpm12020245
doi: 10.3390/jpm12020245
pmc: PMC8880050
pii:
doi:
Types de publication
Editorial
Langues
eng
Références
J Pers Med. 2021 Jul 26;11(8):
pubmed: 34442364
J Pers Med. 2021 Jun 05;11(6):
pubmed: 34198780
J Pers Med. 2021 Jun 08;11(6):
pubmed: 34201198
J Pers Med. 2022 Jan 21;12(2):
pubmed: 35207632
J Pers Med. 2022 Jan 02;12(1):
pubmed: 35055343
J Pers Med. 2020 Nov 25;10(4):
pubmed: 33255761
J Pers Med. 2021 Jun 12;11(6):
pubmed: 34204708
J Pers Med. 2021 Mar 31;11(4):
pubmed: 33807308
J Pers Med. 2021 Nov 02;11(11):
pubmed: 34834488
J Pers Med. 2022 Jan 08;12(1):
pubmed: 35055390